Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 12,854

Document Document Title
WO/2012/010752A1
The invention relates to a process for preparing salts of formulae (RfSO3)n Xn+ (I) or [(RfSO2)(RSO2)N]nXn+ (II) in which: - Rf represents any radical comprising one or more fluorine atoms, - n is an integer varying from 1 to 6, - X is a...  
WO/2011/109047A3
Sulfometh lsuccinates of the formula I, wherein R is an alkyi, alkenyl, alkynyl, alkoxylated alkyi, cycloalkyl, cycloalkenyl, cycloalkynyl, branched alkyi, branched alkenyl, branched alkynyl, branched alkoxylated alkyi, aromatic, substit...  
WO/2011/151669A1
The present invention relates to an economic and efficient process for producing enatiomerically enriched 3-(1-aminoethyl)phenyl derivative and employing the same to produce Rivastigmine or its pharmaceutically acceptable salt.  
WO/2011/143819A1
Disclosed a process for preparing a phenol ortho-substituted by an electron-donating group and protected in the form of a sulphonic ester which comprises reacting a phenol ortho- substituted by an electron-donating group with a sulphonyl...  
WO/2011/104724A3
The present invention relates to a process for the preparation of triflic acid by chloroxidation.  
WO/2011/063268A3
Described herein are xanthine-containing compounds and processes for their synthesis.  
WO/2011/134763A1
The invention relates to a new process for the production and/or purification of the salt of the compound (S)-2-[4-(2-fluorobenzyloxy) benzylamino]propanamide, i.e. ralfinamide, or the respective R-enantiomer, with methanesulfonic acid i...  
WO/2011/130831A1
There is provided a crystalline form of Lapatinib, termed APO-I, and methods for making APO-I. There is also provided a crystalline solvate form of Lapatinib, termed APO-II, and methods for making APO-II.  
WO/2011/068732A3
A process for preparing a highly overbased magnesium alkyltoluene sulfonates comprising: (A) reacting at least one oil soluble alkyltoluene sulfonic acid and at least one source of magnesium, in the presence of a mixture comprising: (i) ...  
WO/2011/118843A1
Glutamate derivatives represented by general formula (I) or salts thereof; pharmaceutical compositions containing these compounds; and CaSR agonists containing the compounds. In general formula (I), R1, R2, R3, R4 and R5 are each indepen...  
WO/2011/113718A1
The present invention relates to a cosmetic composition containing a combination i) of at least one screening agent of the dibenzoylmethane derivative type and ii) of at least one particular hydrophilic or water-soluble merocyanin UV-scr...  
WO/2011/062988A3
A process for preparing an alkylaryl sulfonate comprising (a) reacting at least one meta-xylene compound with olefin or a mixture of olefins having from about 10 to about 20 carbon atoms, in the presence of an acid catalyst, wherein the ...  
WO/2011/111762A1
Disclosed are a novel binaphthyl derivative, a novel formylarene derivative and a method capable of producing diaryl derivatives having an asymmetric structure or formylarenes having two specific substituent groups. Using a diformyl-diar...  
WO/2011/053764A3
The present invention describes an approach to increase taurine or hypotaurine production in prokaryotes or eukaryotes. More particularly, the invention relates to genetic transformation of organisms with genes that encode proteins that ...  
WO/2011/049940A3
There is disclosed a process for making a mono-lithium salt of 5-sulfoisophthalic acid (LiSIPA) having less than 200 ppm sulfate. The process uses a reaction mixture of acetic acid, water, a lithium cation producing compound, and 5-sulfo...  
WO/2011/108690A1
The disclosed composition containing a compound represented by general formula (I) (refer to the Description for the definitions of the symbols used in the formula), or a salt thereof, has excellent CaSR agonist effects and provides phar...  
WO/2011/108563A1
A heat-stable solution of an alkyl methanesulfonate in an aromatic organic solvent can be prepared by: reacting an alkyl alcohol with methanesulfonyl chloride in an aromatic organic solvent in the presence of a tertiary amine; and then s...  
WO/2011/109047A2
Sulfometh lsuccinates of the formula I, wherein R is an alkyi, alkenyl, alkynyl, alkoxylated alkyi, cycloalkyl, cycloalkenyl, cycloalkynyl, branched alkyi, branched alkenyl, branched alkynyl, branched alkoxylated alkyi, aromatic, substit...  
WO/2011/107465A1
The invention relates to a method for producing 4-chlorobenzene sulphonic acid from 2-chlorobenzene sulphonic acid and/or 3-chlorobenzene sulphonic acid, comprising the reaction of 2-chlorobenzene sulphonic acid and/or 3-chlorobenzene su...  
WO/2011/108724A1
An object is to provide a CaSR agonist agent that has excellent CaSR agonist effects, and particularly, a pharmaceutical product that can prevent or remedy diabetes or obesity by the effect of CaSR activation. The aforementioned object i...  
WO/2011/104127A1
The invention pertains to a compound generating an acid of the formula (I) or (II), for instance corresponding sulfonium and iodonium salts, as well as corresponding sulfonyloximes, Formula (I) and Formula (II), wherein X is CH2 or CO; Y...  
WO/2011/040497A9
Disclosed is a method wherein RH 2ORH 1SO2F is added to hydrofluoric acid so as to form a thick solution (hydrogen bonded complex) and the solution is directly supplied to a liquid phase reaction system in which an F2 gas is used, or alt...  
WO/2011/091719A1
Crystalline hydrates of alkyl acyl acetaldehyde sulfites, preparation methods and uses thereof. The molecular formula of the hydrates of alkyl acyl acetaldehyde sulfites is CnH2n+1C(O)CH2CH(OH)SO3M·mH2O, wherein n=8-14, m=0.2-1.5, M is ...  
WO/2011/093497A1
Provided is a plasma oxidation-reduction method with which it is possible to control the structure of amino acids and proteins with high and stable reproducibility, by using plasma in order to control the amino acids and proteins that ma...  
WO/2011/093371A1
A process for producing a perfluorobutanesulfonic acid salt (PFBS salt) is provided with which it is possible to attain an improvement in yield and a reduction in PFOS salt content. Electrolytic fluorination is conducted in an electrolyt...  
WO/2011/093139A1
Disclosed is a sulfonic acid derivative that is characterized by being represented by general formula (1). (1) RCOOCH2CH2CFHCF2SO3 -M+ (In formula (1), R represents a substituted or unsubstituted C1-30 linear, branched, or cyclic hydroca...  
WO/2011/088972A1
The invention relates to sulfosuccinates of the general formula (1), where M is hydrogen or a cation and the groups R4 and R5 - independently of each other - are hydrogen or a cation or an alkyl group, wherein no more than one of the gro...  
WO/2011/037975A3
The present invention describes the method of making anionic ether sulfate surfactants by alkoxylation of a GA using PO and/or EO followed by a sulfation reaction. The GA of the present invention is made by a facile and inexpensive metho...  
WO/2011/025267A3
The present invention relates to metformin methanesulfonate, to a method for preparing same, to a pharmaceutical composition comprising same, and to a combined formulation comprising same. The metformin methanesulfonate of the present in...  
WO/2011/025269A3
The present invention relates to metformin taurate, to a method for preparing same, to a pharmaceutical composition comprising same, and to a combined formulation comprising same. The metformin taurate of the present invention has superi...  
WO/2011/085339A1
An overbased alkylated arylalkyl sulfonate is easy to prepare and is useful as a detergent in various lubricant applications.  
WO/2011/077941A1
A radiation-sensitive resin composition comprising: a compound (A) represented by general formula (A) (wherein R1 and R2 independently represent a substituted or unsubstituted univalent hydrocarbon group having 1 to 25 carbon atoms; X an...  
WO/2010/063403A8
The invention relates to the compounds suitable for radiolabeling with a chelator free radioisotope and radiolabeled compounds of the general Formula (I). Said compounds are ornithine or lysine derivatives.  
WO/2011/066706A1
A non-halogen activating agent, which is the sulfonate formed by sulfonic acid reacting with an organic base,is provided as flux. The sulfonic acid can be alkyl sulfonic acid, alkyl disulfonic acid, hydroxyl sulfonic acid, halogenated ...  
WO/2011/008570A3
Provided are new anionic surfactants and methods of their preparation and use. The surfactants are compounds of the formula I: wherein R, R1, R2, R3, R4, R5, and R6 are as defined herein.  
WO/2011/068732A2
A process for preparing a highly overbased magnesium alkyltoluene sulfonates comprising: (A) reacting at least one oil soluble alkyltoluene sulfonic acid and at least one source of magnesium, in the presence of a mixture comprising: (i) ...  
WO/2011/064216A1
The present invention relates to novel pharmaceutically acceptable salts of R(+)-N-propargyl-1-aminoindane (rasagiline), to processes for their preparation and to pharmaceutical compositions containing them.  
WO/2011/062182A1
Provided are a photo-acid generator having good development properties and a cation polymerization initiator having good curing properties, and also provided are a resist composition and cation polymerizable composition that use the phot...  
WO/2011/062988A2
A process for preparing an alkylaryl sulfonate comprising (a) reacting at least one meta-xylene compound with olefin or a mixture of olefins having from about 10 to about 20 carbon atoms, in the presence of an acid catalyst, wherein the ...  
WO/2011/058789A1
Disclosed is a quinonediazide photosensitizer solution comprising a quinonediazide photosensitizer dissolved in an organic solvent so that the precipitation of the quinonediazide photosensitizer from a positive-type resist composition ca...  
WO/2011/058915A1
Disclosed is a process for producing a high-purity aromatic sulfonyl chloride compound readily, on an industrial scale, and with high efficiency. A reaction product produced by reacting sulfuryl chloride, N,N-dimethylformamide and sulfur...  
WO/2011/054530A1
Disclosed are compounds of formula (I) that inhibiting GPBP activity, making them useful as therapeutics in antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding and ER stress-mediated disorders, and aberra...  
WO/2011/054703A1
The invention relates to a method for handling aqueous solutions of methanesulfonic acid in devices consisting of austenitic steel having a chromium content of between 15 and 22 wt. % and a nickel content of between 9 and 15 wt. %.  
WO/2011/051375A1
(R,S) 2-aryl-propionamide derivatives, or their single enantiomers (R) and (S) are disclosed useful in the treatment or prevention of symptoms and disorders such as pain and inflammation associated with the bradykinin B1 pathway.  
WO/2011/022429A3
The present invention relates to a process for the preparation of alkyl esters of (S) 2-amino-5-cyclopropyl-4,4-difluoropentanoic acid, which are intermediates useful in the synthesis of (S)-N-(1-cyanocyclopropyl)-5-cyclopropyl-4,4-diflu...  
WO/2010/148177A3
Embodiments of the present disclosure provide for chloride channel or transporter compounds or compositions (inhibitors or agents), methods of synthesizing these compounds or compositions, methods of treatment using these compounds or co...  
WO/2011/048919A1
Disclosed are: a radiation-sensitive resin composition which can response to (extreme) far ultraviolet rays such as a KrF excimer laser and an ArF excimer laser, X-rays such as a synchrotron radiation beam, and electron beams effectively...  
WO/2011/049940A2
There is disclosed a process for making a mono-lithium salt of 5-sulfoisophthalic acid (LiSIPA) having less than 200 ppm sulfate. The process uses a reaction mixture of acetic acid, water, a lithium cation producing compound, and 5-sulfo...  
WO/2011/040497A1
Disclosed is a method wherein RH 2ORH 1SO2F is added to hydrofluoric acid so as to form a thick solution (hydrogen bonded complex) and the solution is directly supplied to a liquid phase reaction system in which an F2 gas is used, or alt...  
WO/2011/037975A2
The present invention describes the method of making anionic ether sulfate surfactants by alkoxylation of a GA using PO and/or EO followed by a sulfation reaction. The GA of the present invention is made by a facile and inexpensive metho...  

Matches 651 - 700 out of 12,854